Stock investors often rely on fundamental ratios to evaluate whether a company’s shares are attractively valued, fairly priced, or overvalued. Among the most widely used are the Price-to-Earnings (P/E) ratio, Price-to-Sales (P/S) ratio, Price-to-Earnings Growth (PEG) ratio, and Price-to-Book (P/B) ratio. Each of these measures captures a different perspective on valuation, and together they help investors build a more complete picture of a company’s financial standing and future prospects.
The P/E ratio is perhaps the most common valuation tool. It compares a company’s stock price to its earnings per share (EPS), essentially showing how much investors are willing to pay for each dollar of profit. A higher P/E ratio generally suggests that investors expect stronger future growth, while a lower P/E ratio may indicate undervaluation or weaker growth expectations. As regards to determining undervaluation, a P/E of less than 15 is good.
Within the P/E category, there is an important distinction between the trailing P/E and the forward P/E. The trailing P/E is based on the company’s actual earnings over the past twelve months, making it a snapshot of current profitability relative to stock price. By contrast, the forward P/E uses analysts’ earnings forecasts for the next twelve months, offering a more forward-looking perspective. While the forward P/E can highlight growth potential, it also carries greater risk of inaccuracy since it depends on estimates rather than historical data.
The Price-to-Sales ratio, or P/S ratio, provides another lens for valuation. Instead of focusing on profits, which can be influenced by accounting choices and one-time charges, the P/S ratio compares a company’s stock price to its revenue per share. This makes it especially useful for evaluating companies that are not yet profitable or are experiencing earnings volatility, such as startups or firms in cyclical industries. A lower P/S ratio may suggest that a stock is undervalued relative to its sales, though it should be interpreted in the context of profit margins and industry standards. A P/S ratio of less than 1 is considered good in terms of undervaluation of a stock.
The PEG ratio adds another layer of nuance by combining the P/E ratio with expected earnings growth. It divides a company’s P/E ratio by its projected annual earnings growth rate, providing a measure of whether the stock’s valuation is justified by its growth prospects. A PEG ratio of 1.0 is often seen as “fair value,” with higher numbers suggesting that investors are paying a premium for growth and lower numbers signaling potential undervaluation. The PEG ratio is particularly helpful for growth stocks, where high P/E ratios might otherwise appear expensive without considering the company’s future earnings potential.
The Price-to-Book ratio, or P/B ratio, compares a company’s stock price to its book value per share, which represents the net asset value of the company recorded on its balance sheet. This ratio is especially relevant for industries with significant tangible assets, such as financial institutions, real estate, and manufacturing. A P/B ratio below 1.0 can indicate that a stock is trading for less than the value of its assets, potentially signaling a bargain. However, in asset-light industries like technology, where intangible assets such as intellectual property drive value, the P/B ratio may be less meaningful.
Here are three companies all of which have all favorable ratios:
(MOS) The Mosaic Company
Trailing P/E: ~11.6
Forward P/E: Lower, roughly 10.8. This reflects analysts’ estimates of future earnings being higher than what was earned in the past twelve months.
P/S (Price-to-Sales): Trailing P/S is about 0.96, forward P/S about 0.76.
P/B (Price-to-Book): MOS has a P/B of roughly 0.87. That is, the stock is trading below book value per share.
PEG: MOS’s PEG ratio is approximately 0.88. That means relative to its expected earnings growth, the stock appears modestly undervalued (a PEG below 1 is often seen as potentially favorable, depending on growth risk, etc.).
Interpretation for MOS: The forward P/E being lower than the trailing P/E suggests that earnings are expected to improve. Combined with a PEG under 1, and a P/B less than 1, it may indicate the market is not fully pricing in MOS’s growth or is cautious for some reason (commodity price risk, fertilizer demand, regulatory risk, etc.). The P/S near 1 also means price is roughly equivalent to sales, but profitability margins will matter a lot in assessing how attractive that is.
(GT) Goodyear Tire & Rubber
Trailing P/E: ~ 6.0.
Forward P/E: ~ 6.36. This is higher than its trailing P/E, suggesting that earnings are expected to be lower (or the growth is not strong) or that recent earnings were unusually good or a one-off.
P/S: Very low, around 0.13 trailing and forward.
P/B: ~ 0.48. The stock is trading well below its book value per share.
PEG: ~ 0.41 according to one source.
Interpretation for GT: Goodyear’s low trailing P/E, low P/S, and fairly low P/B suggest the market is strongly discounting its earnings prospects or anticipating trouble. The fact that forward P/E is higher than trailing P/E might suggest either earnings are expected to decline or that trailing earnings were boosted in the recent period. A PEG of ~0.48 might look attractive on its face, but one must question whether the growth assumptions underlying that PEG are realistic. For cyclical and capital-intensive businesses like tire manufacturing, external factors (rubber prices, labor costs, supply chain, demand cycles) can cause big swings.
(BFH) Bread Financial Holdings
Trailing P/E: ~ 10.8
Forward P/E: 7.0
P/S: 0.63
P/B: 0.94
PEG: 0.97
Interpretation for BFH: With a trailing P/E of about 10.6×, BFH is not extremely expensive on a historical earnings basis, and with a much lower forward P/E, further earnings growth is expected.
These examples illustrate how the fundamental ratios give different lenses — trailing vs forward P/E to see past vs expected earnings; P/S when profits might be volatile; P/B when assets matter; PEG to combine valuation with growth.
Taken together, these four fundamental ratios—P/E, P/S, PEG, and P/B—help investors analyze stocks from multiple angles, balancing current profitability, revenue generation, growth potential, and underlying asset value. None of them should be used in isolation, as industries and business models vary widely, but when combined they form a powerful toolkit for making informed investment decisions.
Disclosure: Author didn’t own any of the above at the time the article was written. No recommendations are expressed or implied.
The following is a short list of some of the many stocks going ex-dividend during the next month, which can be helpful for traders and investors interested in the stock trading technique known as “Buying Dividends” or “Dividend Capture.” This strategy involves purchasing stocks before the ex dividend date and selling them shortly after the ex-date at a similar price, while still being eligible to receive the dividend payment.
Although this dividend capture strategy generally proves effective in bull markets and flat or choppy markets, it is advisable to exercise caution and consider avoiding this strategy during bear markets. To qualify for the dividend, it is necessary to buy the stock before the ex-dividend date and refrain from selling it until on or after the ex-date.
However, it is important to note that the actual dividend may not be paid for several weeks, as the payment date may not be until two months after the ex-dividend date.
For investors seeking a comprehensive list of stocks going ex-dividend in the near future, WallStreetNewsNetwork.com has compiled a downloadable list containing numerous dividend-paying companies. Here are a few examples showcasing the stock symbol, ex-dividend date, periodic dividend amount, and annual yield.
QUALCOMM Incorporated (QCOM)
9/4/2025
0.89
2.21%
PepsiCo, Inc. (PEP)
9/5/2025
1.4225
3.83%
Alphabet Inc. Class A (GOOGL)
9/8/2025
0.21
0.39%
NVIDIA Corporation (NVDA)
9/11/2025
0.01
0.02%
Nasdaq, Inc. (NDAQ)
9/12/2025
0.27
1.14%
T. Rowe Price Group, Inc. (TROW)
9/15/2025
1.27
4.72%
Xcel Energy Inc. (XEL)
9/15/2025
0.57
3.15%
Xerox Holdings Corporation (XRX)
9/30/2025
0.025
2.51%
To access the entire list of over 100 ex-dividend stocks, subscribers will receive an email in the next couple days with the full list. If you are not already a subscriber, you can sign up using the provided signup box below. Don’t miss out on this valuable information, and the best part is that it’s free!
Dividend Definitions
To better understand the dividend-related terms, let’s define them:
Declaration date: This refers to the day when a company announces its intention to distribute a dividend in the future. Ex-dividend date: On this day, if you purchase the stock, you would not be eligible to receive the upcoming dividend. It is also the first day on which a shareholder can sell their shares and still receive the dividend. Record date: This marks the day when you must be recorded on the company’s books as a shareholder to qualify for the dividend. Typically, the ex-dividend date is set two business days prior to the record date. Payment date: This is the day on which the dividend payment is actually made to the eligible shareholders. It’s important to note that the payment date can be as long as two months after the ex-date.
Before implementing the “Buying Dividends” technique, it is crucial to reconfirm the ex-dividend date with the respective company to ensure accuracy and avoid any unexpected changes.
In conclusion, being aware of the stocks going ex-dividend can be advantageous for traders and investors employing the “Buying Dividends” strategy. WallStreetNewsNetwork.com provides a convenient resource to access a comprehensive list of such stocks, allowing individuals to plan their investment decisions effectively. Remember to stay informed and consider market conditions before employing any investment strategy.
Disclosure: Author may have positions in some of the above at the time the article was written.
Earlier this month, a book written by Harry Houdini that included his signature went up for auction at Potter & Potter Auctions, with a starting bid of $3,000 and an estimate of $6,000 to $12,000. After much spirited bidding, the item was hammered at $50,400.
As an investor, you may be looking for an item that is more reasonably priced and connected to stocks and bonds. You could consider a Houdini Picture Corporation stock certificate, handsigned by Harry Houdini, which would probably be priced between $6,000 and $10,000.
In the world of alternative investments, few assets offer the unique blend of financial potential and tangible history as autographed documents, particularly antique stock certificates and other historical papers bearing the signatures of the famous. Beyond the value of the paper itself, a signature from a titanic figure—be it a President, a titan of industry, or a cultural icon—transforms a simple document into a coveted collectible and a compelling investment.
For the savvy collector, historic documents signed by famous figures, a field known as scripophily when focusing on stock certificates and bonds, are gaining significant attention. But as with any investment, prudence, authentication, and proper care are the pillars of success.
The Financial Lure of a Famous Hand
The value of an autographed document is determined by several key factors: The signer’s fame, the rarity of their signature, the condition of the document, and the historical significance of the item itself.
Antique stock certificates, which once represented shares of ownership in companies, are a prime example. While a certificate from a defunct company may be financially worthless as a security, a signature from an influential founder like J. P. Morgan, on a New Jersey Junction Railroad bond, or Henry Wells and William Fargo, on an American Express stock, can catapult its value into the thousands, or even tens of thousands, of dollars. Even some modern certificates with a noted signature can command around a thousand dollars, such as Jack Tramiel’s signature on an Atari stock.
Key Financial Benefits:
Appreciation Potential: Signatures of historical and cultural icons, especially those whose output was limited or who died young, exhibit strong long-term appreciation due to finite supply and enduring demand.
Tangible Asset: Unlike digital assets, a historic document is a physical, hard asset that can be viewed, held, and displayed.
Historical Context: Signatures on documents that relate directly to the person’s historical legacy (e.g., an Abraham Lincoln-signed military document) command a premium over a simple “cut” signature. The convergence of history and autograph creates exceptional value.
Diversification: Collectibles offer a degree of portfolio diversification, often performing independently of traditional financial markets.
The Importance of Authentication: Vetting Your Investment
The market for autographs is lucrative, which, unfortunately, makes it a target for counterfeiters. Forging a famous signature is far easier than printing millions of dollars in banknotes. For investors, authenticity is an important factor.
This is where respected Third-Party Authentication, also referred to as TPA, services come into play. Organizations like PSA/DNA (Professional Sports Authenticator) and Beckett Authentication Services (BAS) employ forensic analysis, comparing signatures against extensive databases of known genuine examples.
Why TPA is Essential:
Establishes Credibility: A TPA certificate of authenticity (COA) provides a court-approved chain of evidence, instilling buyer confidence and eliminating doubt about the item’s legitimacy.
Enhances Market Value: Items authenticated by major services consistently sell for significantly higher prices than unauthenticated pieces. A TPA COA acts as a verifiable pedigree.
Protection Against Fraud: The forensic methods used by these services—analyzing ink, paper aging, and signature fluidity—are the best defense against sophisticated forgeries.
If the item is not already authenticated but you want the Certificate of Authenticity, factor the cost of TPA into your investment budget.
Preservation is Protection: The Importance of Safe Storage
An autographed document is a fragile piece of history, vulnerable to its environment. Failure to store it correctly can lead to irreparable damage, fading the ink and degrading the paper, thus destroying its financial value. Preservation is not just care; it is an act of financial protection.
Best Practices for Storing Historic Autographed Documents:
Climate Control is Key: Store documents in a cool, dry place with stable temperature and humidity (ideally 65–75°F and 35–55% relative humidity). Avoid high-risk areas like basements, attics, and garages, where fluctuations can cause warping, mold, or mildew.
Go Acid-Free: Paper and acidic storage materials will yellow and become brittle over time. Use only acid-free, archival-quality materials. Store unframed documents in Mylar or other acid-free sleeves and place them inside archival storage containers.
Light is the Enemy: Ultraviolet (UV) light from the sun and fluorescent bulbs will rapidly fade most inks, especially dye-based and certain other pen inks.
Displaying: If framing, use only UV-filtering glass or acrylic and acid-free matting. Hang framed pieces away from direct sunlight.
Storage: Keep stored documents in a dark environment.
Avoid Destructive Fasteners: Immediately remove metal fasteners like paper clips and staples, as they will rust and stain the paper. Also, never use common adhesive tapes (like clear or masking tape) for repairs, as their adhesives will permanently damage and stain the document.
Handling: Always handle documents with clean, dry hands. For paper documents, wearing clean cotton or nitrile gloves is a prudent step to prevent the transfer of dirt and natural oils.
By carefully curating a collection, considering reputable third-party authentication, and prioritizing archival-quality storage, investors can ensure that their autographed historic documents not only serve as a direct link to the past but also as a sound financial asset for the future. These collectibles can be a rewarding and financially sound addition to any portfolio.
The healthcare sector, particularly managed‑care insurers, has been under pressure recently, driven by rising medical costs, regulatory scrutiny, earnings disappointments, and reputational challenges. Many of these companies’ stocks have significantly lagged the broader market, and investors are grappling with whether these sectors present contrarian value opportunities or structural pitfalls.
A high‑profile case is UnitedHealth (UNH): after a December 2024 incident—the murder of its insurance‑division CEO Brian Thompson—plus unexpected medical cost overruns and a DOJ investigation, the company endured a painful sell‑off. Its stock plunged by around half year‑to‑date earlier in 2025.
Yet, in a classic “buy the dip” moment, Warren Buffett’s Berkshire Hathaway added over 5 million UNH shares (worth approximately $1.6 billion) by end of June. This triggered a “Buffett Bounce,” with UNH shares rising substantially upon the announcement, Analysts now see UNH as undervalued, with forward P/E at or below historical norms, a decent dividend yield (~3%), and a consensus Buy rating with upside potential above 20%.
This recovery has pulled other managed‑care stocks—including Elevance Health (ELV)—into renewed investor focus, with many seeing longer‑term upside as the sector’s economic fundamentals reassert themselves.
Stock Profiles
UnitedHealth (UNH)
Once a Wall‑Street favorite for consistent profits and dominant scale, UNH now contends with broad operational headwinds. It slashed its 2025 earnings guidance to around $16 per share (vs. ~$20.64 expectation and prior guidance of $30+), due to soaring costs, Medicare reimbursement challenges, and regulatory and legal complications. The company faces intensive scrutiny, including criminal probes related to Medicare billing and claims practices.
However, for value investors, the valuation reset is significant. With Buffett’s entry and positive analyst sentiment, some see UNH as a turnaround play—not without risks, but potentially rewarding for those betting on operational reforms under returning CEO Stephen Hemsley and cost containment initiatives.
The stock, with a market cap of $275 billion, trades at 13 times trailing earnings and 17 times forward earnings. It carries a favorable Price to Sales Ratio of 0.65, and provides a yield of 2.8%.
Cigna (CI)
Two months ago, Cigna was trading near $297, with relatively muted volatility compared to peers. Cigna aligns with the broader managed‑care sector and likely shares similar cost and regulatory pressures. Its profile suggests steadiness and defensive appeal, though without the explosive risk/reward of UNH at current levels.
This $79 billion market cap stock has a trailing price to earnings ratio of 16 and a forward P/E of 9. The price to sales ratio is an excellent 0.30. The stock sports a yield of about 2.5%.
CVS Health (CVS)
CVS encompasses pharmacy chains, PBM services, and Aetna’s insurance plans. Although CVS’s integrated model offers resilience, its exposure to Medicare Advantage and cost pressures mirrors peers. Reports indicate investor focus on whether CVS can sustain momentum under its current management amid sector‑wide headwinds.
The stock has a market cap of $96 billion, a trailing P/E of 19, and a forward P/E of 9.6.The price sales ratio is a superior 0.23, with a fairly high yield of 3.9%.
Elevance Health (ELV)
Elevance Health was formerly Anthem. Analysts hold a bullish consensus “Buy” rating, with a 12‑month price target near $412—implying about 33% upside.
Elevance’s valuation appears attractive, with forward P/E near 10, following a 13 trailing P/E, and dividend yield around 2.2%. Though it has trended down from a 52‑week high over $567, the volatility is modest and relative fundamentals solid. Market forecasts place it as a stable performer in managed‑care. The market cap is $69.7 billion.
Conclusion
The current landscape offers a mix of risks and opportunities across healthcare plan stocks, the following which all have dividend yields above 2%:
UnitedHealth (UNH) represents high-risk, high-reward territory. The battered valuation, combined with Buffett’s backing and potential for operational recovery, may appeal to contrarian, value-minded investors—but only for those comfortable with regulatory and reputational risks.
Elevance Health (ELV) strikes a compelling balance between stability, valuation, and growth potential. With solid fundamentals and moderate upside, it’s positioned for cautious optimism.
Cigna (CI) and CVS Health (CVS) are less volatile and potentially more defensively oriented—though sector-wide headwinds remain a concern.
For investors evaluating this sector, the decision likely hinges on risk tolerance and time horizon: are you looking for a possible rebound champion (UNH), a strong core holding (ELV), or stable, less dramatic exposure (CI) and (CVS)? Investors attracted to contrarian, value-oriented plays may find the sector appealing right now. However, the path forward depends on successful cost management, legal clarity, and renewed growth momentum.
Disclosure: Author didn’t own any of the above at the time the article was written. No investments are expressed or implied.
For investors seeking an edge in the stock market, observing the actions of company insiders can offer valuable insights. “Insider buying” refers to the purchase of a company’s shares by its own executives, directors, or other key employees. These individuals have intimate knowledge of the company’s operations, future plans, and overall health, making their investment decisions potentially significant signals for external investors.
Why might insider buying be a favorable sign? The rationale is straightforward: insiders are likely to buy their company’s stock when they believe it is undervalued and has the potential for future growth. Their personal capital is at stake, suggesting a strong conviction in the company’s prospects. This can be seen as a vote of confidence from those with the most in-depth understanding of the business. While insider buying doesn’t guarantee stock price appreciation, it can be a compelling indicator that aligns with a positive outlook for the company.
Here are a few stocks that have shown notable recent insider buying activity, along with a brief profile and recent financial highlights:
Asbury Automotive Group, Inc. (ABG)
Profile: Asbury Automotive Group is one of the largest automotive retailers in the United States. It operates through a network of dealerships offering a wide range of new and used vehicles, as well as related services such as parts, vehicle maintenance, and finance and insurance products. The company has a significant presence across multiple states and represents numerous domestic and foreign brands.
Recent Financial Information: The company has a market cap of $4.37 billion. The stock trades at 8.1 times trailing earnings and 8.2 times forward earnings, and sports an extremely favorable price to sales ratio of 0.25. Earnings per share growth was over 40% year-over-year on a revenue growth of 8.4%. Recently, several insiders, including a director, have been reported to have purchased shares of ABG in the open market. Insider ownership jumped 53% in the last six months.
Marriott Vacations Worldwide Corporation (VAC)
Profile: Marriott Vacations Worldwide is a leading global vacation company that offers vacation ownership, exchange, rental, and resort and property management services. The company develops, markets, sells, and manages vacation ownership interests under the Marriott Vacation Club®, Grand Residences by Marriott®, Sheraton Vacation Club®, Westin Vacation Club®, The Ritz-Carlton Destination Club®, and St. Regis Residence Club® brands.
Recent Financial Information: The company has a market cap of $2.45 billion. The stock has a trailing price to earnings ratio of 10.7 and a forward P/E of 9.2. It has an excellent price to sales ratio of 0.48 and is even selling below book value. Earnings per share growth skyrocketed over 63% year-over-year on a revenue growth of 7.7%. In recent filings, multiple insiders, including executive officers, have disclosed purchases of VAC stock in the open market, with net insider buying transactions increasing by 33.3%.
Victoria’s Secret & Co. (VSCO)
Profile: Victoria’s Secret & Co. is a leading specialty retailer of lingerie, pajamas, and beauty products. The company operates through its Victoria’s Secret and PINK brands, offering a wide assortment of apparel, fragrances, and accessories. Victoria’s Secret sells its products through stores and online channels globally.
Recent Financial Information: The company, which has a market cap of $1.69 billion, trades at 10.6 times trailing earnings and 9.9 times forward earnings, and offers a very favorable price to sales ratio of 0.27. Earnings per share growth was over 59% year-over-year on a revenue growth of 1.4%. Notably, several insider transactions indicate open market purchases of VSCO stock by directors and executive officers, with a net increase of more than 22% during the last six months.
Important Considerations:
While insider buying can be an encouraging sign, it’s crucial to remember that it’s just one piece of the investment puzzle. Investors should conduct thorough due diligence, analyzing the company’s financials, industry trends, and overall market conditions. Insider selling, for instance, doesn’t necessarily indicate a negative outlook, as insiders may sell for various personal financial reasons. Furthermore, the volume and frequency of insider buying activity should be considered. Small, infrequent purchases might not carry the same weight as large, consistent buying by multiple insiders.
Conclusion:
Tracking insider buying activity can provide valuable insights into how company executives view their own stock’s prospects. When multiple insiders are putting their own money into the company, it can suggest a belief in future positive performance. However, it should always be used in conjunction with a comprehensive investment strategy that includes fundamental analysis and risk assessment. By considering insider buying as one indicator among many, investors can potentially identify undervalued opportunities and make more informed investment decisions.
Please remember that this article and all our articles are for informational purposes only and should not be considered financial advice. Always consult with a qualified financial advisor before making any investment decisions.
Disclosure: Author didn’t own any of the above at the time the article was written.
Recent weeks have been characterized by intense market activity, but this activity is not uniform. The most prominent and influential sectors have been Information Technology and Communication Services, where performance is being driven by the relentless advancement of generative AI and strong growth in the digital engagement economy. These sectors, which represent a significant portion of the S&P 500, have been the primary engines of the market’s recent rally.
However, the term “active” also encompasses periods of extreme volatility and weakness. This is most acutely demonstrated in the Healthcare sector, which has been highly active due to a dramatic bifurcation in performance. A major sell-off in the health insurance sub-industry, triggered by fundamental business challenges and disappointing earnings, stands in stark contrast to robust growth and investor confidence in pharmaceuticals and biopharma. The broader market is navigating a complex macroeconomic landscape. While optimism over strong corporate earnings and the potential for a Federal Reserve rate cut provides a powerful tailwind, this is tempered by persistent risks from rising bond yields and escalating geopolitical tensions over tariffs. This dynamic creates a push-pull effect, demanding a highly selective and data-driven investment approach from market participants.
The Macroeconomic Backdrop: A Push-Pull Market Environment
To properly understand the recent trends in specific industries, it is essential to first analyze the broader macroeconomic context. The market has been operating in a complex environment defined by a combination of positive catalysts and persistent risks.
The overall sentiment has been cautiously optimistic, leading to positive performance in the major US stock indexes. The S&P 500 recently rose 0.8% in a single day, leaving it just shy of a new record set the previous week. The Nasdaq composite, which is heavily weighted toward technology and growth companies, added 1% to reach a new record high.Over a trailing one-month period, the S&P 500 has climbed 2.01% and is up 19.56% year-over-year. The Nasdaq has also shown significant strength, rising 3.9% over the past week and 11.1% over the last four weeks. The fact that the Nasdaq Composite is reaching new records while the S&P 500 and Dow Jones Industrial Average are showing more modest gains suggests that the current market rally is not a broad-based, all-boats-rising tide. Instead, it indicates that capital is disproportionately flowing into the technology and communication services sectors, which are the primary constituents of the Nasdaq. This targeted rally supports the central thesis that these specific sectors are highly active and influential.
The market is also contending with a series of significant economic drivers and risks. A major source of optimism stems from the prospect of potential interest rate cuts by the Federal Reserve later in 2025. This sentiment was strengthened following a weaker-than-expected US jobs report, which firmed up expectations for a rate cut at the Fed’s policy meeting in September. The possibility of lower interest rates is generally seen as a positive for equities, as it can reduce borrowing costs and stimulate economic activity. However, this positive force is being counteracted by persistent risks from rising bond yields. A rise in the “term premium”—the additional compensation lenders demand for longer-term loans—has been putting upward pressure on bond yields, which in turn pressures stock price-earnings (P/E) ratios and stock prices. This dynamic is a core reason why some analysts believe the market could be confined to a “trading range” for the remainder of 2025, as this push-pull effect creates natural upper and lower boundaries.
Another significant geopolitical headwind is the return of “hawkish tariff talk”. Investors are concerned that new tariff measures could harm corporate margins and disrupt global trade. This is not a theoretical risk; the decision by the US to raise tariffs on Indian exports to 50% caused a significant sell-off in export-oriented sectors and led to Foreign Institutional Investors (FIIs) pulling billions of dollars out of Indian equities. The market is also operating with major indices near record levels, which places a high burden on companies to deliver exceptional performance to justify their current valuations. With the market not priced for an adverse outcome, any negative news or macroeconomic surprises could trigger significant volatility. This environment underscores the need for selective investing, as only companies with strong fundamentals and innovative growth drivers can sustain investor confidence.
To provide a foundational, data-rich overview of the market’s structure, the following table details the weighting and recent performance of the sectors within the S&P 500.
Sector
Weighting in S&P 500 (%)
Trailing six-month performance (%)
Trailing 12-month performance (%)
Information Technology
31.6
-0.4
14.6
Financials
14.3
0.1
26.1
Consumer Discretionary
10.6
-3.7
21.7
Communication Services
9.6
7.3
20.9
Health Care
9.6
-9.1
-4.7
Industrials
8.7
0.2
18.9
Consumer Staples
5.9
3.1
15.8
Energy
3.0
-13.0
-7.3
Real Estate
2.1
-5.5
15.9
Utilities
2.5
0.4
18.2
S&P 500 Index
-1.3
14.4
Data from Schwab, as of July 18, 2025
The Engines of Growth: Technology and Communication Services
The most active and influential sectors in the market over the last few weeks have been Information Technology and Communication Services. Their outperformance has been driven by a confluence of powerful trends, most notably the generative AI revolution and the continued expansion of the digital engagement economy.
Information Technology: The Generative AI Revolution
The Information Technology sector, with an enormous 34.0% weighting in the S&P 500, has been the single largest driver of overall market performance. The central catalyst for this activity is the ongoing and accelerating generative AI boom. This is not merely a passing trend but a transformative force that is already leading to billions of dollars in productivity gains as companies leverage AI assistants to help human developers write and test code. The demand for computing power to support these workloads is exponentially increasing, capturing the attention of both management teams and the public.
The recent Q2 2025 earnings reports from major tech companies provide concrete evidence of how this trend is translating into tangible financial results. Shares of Meta Platforms (META) jumped 11% to an all-time high following a strong report, with CEO Mark Zuckerberg crediting AI for unlocking greater efficiency and gains in their ad system. Amazon’s (AMZN) revenue grew 13% year-over-year, and its cloud services division (AWS) revenue increased 18%, both exceeding analyst projections. Microsoft (MSFT) also paced sector gains after releasing its earnings report. Even companies like Apple (AAPL), which are seen as less directly involved in AI infrastructure, are benefiting; its iPhone sales climbed 13%, and its total number of active devices reached an all-time high, indicating strong consumer engagement with the digital ecosystem.
The AI story extends far beyond the final software or platform product. It has created a complex value chain that is driving activity in hardware and infrastructure. The semiconductor industry, which is the foundational layer for AI, is projected for double-digit revenue growth in 2025, primarily driven by the surging demand for gen AI chips such as CPUs, GPUs, and data center communications chips. This trend is benefiting a wide range of companies, from market giants to specialized players.
For example, Advanced Micro Devices (AMD) ranked among the best-performing stocks in July 2025, and some analysts see Micron Technology as an undervalued stock to watch, noting that it is the “preferred memory provider” for Nvidia’s latest AI accelerators. The fact that investors are actively pursuing companies in the hardware and memory space demonstrates a thorough understanding of the AI value chain. The demand for compute-intensive workloads is creating new challenges for global infrastructure, from data center power constraints to supply chain delays, which implies that the investment theme will continue to expand into a broader range of infrastructure-related companies.
Communication Services: The Resurgence of Digital Engagement
The Communication Services sector, with a substantial 9.6% weighting in the S&P 500, has also been a highly active area for investors, exhibiting a robust 20.9% performance over the trailing 12 months. This sector relies heavily on advertising and subscription-based revenue, which tends to rise when the economy is expanding. The recent stock activity and corporate results provide a clear picture of this trend in action.
A compelling case study is the performance of Roblox (RBLX), an online gaming and game creation platform. Its stock was one of the best performers in July 2025, with shares soaring by 19.66% in pre-market trading after a strong Q2 earnings report. The exceptional results were driven by significant growth in key metrics: revenue was up 21% year-over-year, bookings increased by an impressive 51%, and Daily Active Users (DAUs) grew by 41% to over 111 million. This growth was fueled by new, viral content, such as the game “Grow a Garden,” which was launched in March 2025 and set a world record for concurrent users in Q2. The fact that DAUs aged 13 and over now account for 64% of total users and 66% of all hours played suggests a maturing user base with significant spending power, signaling strength in the broader digital economy.
The sector’s activity is not limited to gaming. Comcast, a telecommunications and entertainment giant, also saw its stock rise more than 2% after beating earnings estimates. The company’s Q2 results were mixed but showcased strategic strengths; while it lost video and residential voice customers, it saw revenue growth in its domestic broadband and wireless divisions. The company also benefited from the successful opening of its Epic Universe theme park, which led to a 6% growth in its Content and Experiences segment. However, not all companies in the sector fared as well, with Charter Communications being listed as one of the worst-performing stocks of July 2025. This divergence highlights that even within a highly active sector, a selective approach is crucial.
The Paradox of Activity: Healthcare’s Bifurcated Market
The Healthcare sector provides a critical, nuanced perspective on market “activity.” While the sector has a significant weighting in the S&P 500, its recent performance is a study in contradiction. Instead of moving in a single direction, capital flows have been dramatically bifurcated, with investors punishing one sub-industry while rewarding others based on their business models and innovation.
The most dramatic recent market activity in Healthcare has been a major sell-off in the health insurance sub-industry. A cluster of major companies, including Centene and Molina Healthcare, ranked among the worst-performing stocks of July 2025. The reason for the sell-off was not just market sentiment but a series of fundamental business problems. Centene, for example, saw its stock plummet after it pulled its full-year 2025 earnings guidance. The company revealed that enrollment numbers in its health insurance marketplaces were lower than expected and that the enrollees were generally less healthy, leading to a stunning $1.8 billion shortfall in its risk-adjustment program. This is a systemic issue within the managed healthcare industry: the challenge of managing costs in an environment of rising utilization and higher-than-expected patient morbidity. Similarly, Molina Healthcare reported a year-over-year decrease in adjusted net income and a higher Medical Care Ratio (MCR) for its Marketplace business, indicating that the costs of providing care are rising faster than revenue. The fact that this problem is being cited across the sector, with other insurers like UnitedHealth Group also suspending their guidance, demonstrates that this is not an isolated event but a deep-seated challenge facing the business model itself.
In stark contrast, other parts of the Healthcare sector are thriving. A list of “best healthcare stocks to buy” is dominated by companies in drug manufacturers, medical devices, and diagnostics & research. These companies are being rewarded for having strong “economic moats,” which are competitive advantages that protect their long-term profitability. For example, Novo Nordisk (NVO) is highlighted for its dominance in the diabetes and obesity treatment markets, with its innovative GLP-1 therapies providing a strong barrier against competition. Merck is also noted for its strong drug pipeline and high-margin product lineup. This flight to quality and innovation is further evidenced by a list of high-growth technology companies that includes several biopharmaceutical firms, suggesting that investor enthusiasm for technology extends to its application in drug discovery and development. This bifurcated flow of capital is confirmed by the prominence of Pharmaceutical ETFs, which have significant weightings in companies like Eli Lilly, AbbVie, and Johnson & Johnson. The stark difference in performance suggests that investors are actively punishing companies with strained business models while rewarding those with strong, innovation-driven competitive advantages.
The following tables visually represent the divergence in performance within the Healthcare sector and across other industries.
Top Performers (July 2025)
Sector
Underperformers (July 2025)
Sector
Comfort Systems USA (FIX)
Industrials
Centene (CNC)
Healthcare
Roblox (RBLX)
Communication Services
Molina Healthcare (MOH)
Healthcare
GE Vernova (GEV)
Industrials
Charter Communications (CHTR)
Communication Services
PTC (PTC)
Technology
Align Technology (ALGN)
Healthcare
Advanced Micro Devices (AMD)
Technology
Liberty Broadband (LBRDA)
Communication Services
Data from Morningstar, as of August 1, 2025
Conclusion: Implications for Investors and Forward Outlook
The most active industries for stock investors in the last few weeks have been Information Technology and Communication Services, driven by a powerful and concentrated rally around generative AI and digital engagement platforms. These sectors are providing the primary momentum for the broader market, with strong corporate earnings justifying high valuations and fueling investor optimism. However, the term “active” is also defined by a significant and telling divergence, most evident in the Healthcare sector, where investors are fleeing from managed care companies facing systemic cost issues and re-allocating capital toward innovative, moat-protected biopharma and medical device companies.
For investors, this bifurcated market presents a critical lesson: selectivity is paramount. A broad, passive approach to a sector like Healthcare would have been disastrous in July, while a highly selective approach could have yielded significant returns. The outsized influence of a few mega-cap technology stocks presents a concentrated opportunity, but also a risk if those companies fail to deliver. This is reinforced by the broader macroeconomic picture, which suggests a potentially “rangebound” market for the remainder of 2025. This environment highlights the value of diversification, not only across sectors but also into other asset classes like international stocks and precious metals.
The forward trajectory of these active industries will likely be determined by three key factors. First, the pace of AI innovation and adoption will continue to be a primary driver. The market will be watching to see if demand for AI hardware and software can continue to drive earnings, or if scaling challenges and new competitors will temper growth.Second, the market’s direction will be dictated by the delicate balance between corporate earnings and macro policy. Companies must continue to deliver strong results to justify their high valuations, especially in the face of rising bond yields and geopolitical tariff risks. Finally, the Healthcare sector’s path forward depends on how the health insurance sub-industry responds to its fundamental cost challenges, and whether the pharmaceutical sub-industry can continue its innovation-driven growth, which has proven to be a shield against broader market pressures.
Disclosure: Author owns several of the above mentioned stocks including AAPL, AMZN, and MSFT.
The concept of eVTOL aircraft—electric vehicles capable of vertical takeoff and landing—has long captured the imagination of futurists. Today, the industry is rapidly evolving, driven by advances in battery technology, regulatory acceptance, and partnerships with major automakers and airlines. Though often branded as “flying cars,” most eVTOL designs resemble compact air taxis more than vehicles that drive on roads. Still, the promise of speeding up congested city commutes via quiet, emissions‑free aerial vehicles has spurred billions in investment.
As of mid‑2025, several pure‑play eVTOL manufacturers are publicly traded, including Joby Aviation (NYSE: JOBY), Archer Aviation (NYSE: ACHR), Eve Air Mobility (NYSE: EVEX), Vertical Aerospace (NYSE: EVTL), Blade Air Mobility (NASDAQ: BLDE), and EHang (NASDAQ: EH). Below we explore Joby and its peer group from an investor perspective.
Joby Aviation (NYSE: JOBY) stands out as a front‑runner among eVTOL firms. Founded in 2009 and publicly listed via a SPAC in 2021, Joby has developed a five‑seat aircraft targeting FAA certification in 2025, with hopes to launch commercial air taxi service in late 2025 or 2026, starting perhaps in Dubai before U.S. approval arrives. Its key specs—200 mph top speed and about 150 mile range carrying one pilot and four passengers—make it competitive in urban air mobility.
From an investor’s standpoint, Joby has several distinct strengths. It has raised substantial capital—Toyota has committed over $500 million as part of a roughly $894 million investment and is partnering on manufacturing in Ohio; other investors include Baillie Gifford, Intel Capital, and Delta Air Lines. Joby also acquired Uber’s Elevate division in 2020 to integrate with Uber’s ride‑hailing platform. On the regulatory front, Joby became the first eVTOL company awarded a Part 135 Air Carrier Certificate, enabling it to begin limited commercial operations with conventional aircraft as a stepping stone.
However, Joby remains pre‑revenue and heavily cash‑consuming. Milestones like aircraft certification, scaling manufacturing, and commercial deployment must align closely or valuation risk increases sharply. Its recent equity offerings—40 million shares at $5.05 per share—raised about $193–$222 million, intended to help fund certification and production ramp‑up, though dilutive for shareholders. Toyota’s share issuance could further increase dilution while increasing financial runway. Joby currently has a $13.55 billion market capitalization.
Archer Aviation (NYSE: ACHR) is another pure‑play listed firm, co‑founded in 2018 and based in San Jose, California. Its two‑seat Maker eVTOL targets roughly 100 mile range and top speeds near 150 mph. Archer’s high profile partnership with United Airlines includes a $1 billion pre‑order for over 200 aircraft, and it’s targeting commercial operations during the 2028 Los Angeles Olympics. It has also joined forces with defense‑tech firm Anduril to develop hybrid VTOL platforms for Pentagon use, a divergence into potential military markets. Archer recently raised $850 million, boosting its cash posture significantly.
From a financial metrics standpoint, Archer is still pre‑revenue with net losses (about ‑$317 million in 2023), modest assets, and equity; its market cap hovers in the $6.7 billion range, compared to Joby’s larger valuation. Recent moves—such as joining Archer’s defense advisory board by Lt. Gen. Scott Howell (formerly at Joby)—signal investor concerns over Joby’s military momentum and confidence in Archer’s strategy in this domain.
Eve Air Mobility (NYSE: EVEX) is the eVTOL arm of Brazilian aerospace giant Embraer. Eve aims for commercial flights by 2026 and has signed letters of intent for up to 54 aircraft in markets including Brazil and the U.S. Embraer’s backing and engineering heritage offer an institutional advantage, though Eve remains early stage and revenue‑less in practice.
Vertical Aerospace (NYSE: EVTL) is a U.K.-based eVTOL start‑up now trading at a heavily distressed valuation (declined from about $2.2 billion to near $655 million) amid cash shortages and delays. Its planned VX4 aircraft has completed hover testing, but passengerflight certification is postponed to 2028 or later. It is currently negotiating urgent funding to survive.
EHang (NASDAQ: EH) of China is unique in being already profitable, and certified its EH216‑S model for commercial passenger and limited autonomous operations by China’s CAAC in early 2025. That gives it a non‑U.S. foothold in eVTOL operations, but its geopolitical and regulatory environment may introduce separate risks.
Blade Air Mobility (NASDAQ: BLDE) is not a pure eVTOL manufacturer—it operates an existing urban air transport platform, using helicopters and seaplanes—but is often lumped into eVTOL market ETFs due to its air mobility business model. Blade’s near‑term revenue is real, though its transition to eVTOL remains speculative.
For investors evaluating this emerging sector, Joby Aviation leads on certification progress, strategic partnerships, and product maturity. Yet its lack of operating revenue and the risk of dilution remain key vulnerabilities. Archer offers a credible alternative with solid airline and defense links, though it too is pre‑commercial. Firms like Eve and EHang bring institutional and regional advantages, but certification and scaling remain hurdles. Vertical Aerospace underlines how capital constraints and execution risks can result in steep de‑rating.
Overall, this high‑risk, high‑volatility group may fit early‑stage speculative portfolios. Diversifying across multiple players and maintaining discipline around entry valuations and milestones—particularly FAA certification timelines, manufacturing scaling, and initial revenue traction—are prudent steps for would‑be investors betting on the eVTOL revolution.
Disclosure: Author didn’t own any of the above at the time the article was written.
The following is a short list of some of the many stocks going ex-dividend during the next month, which can be helpful for traders and investors interested in the stock trading technique known as “Buying Dividends” or “Dividend Capture.” This strategy involves purchasing stocks before the ex dividend date and selling them shortly after the ex-date at a similar price, while still being eligible to receive the dividend payment.
Although this dividend capture strategy generally proves effective in bull markets and flat or choppy markets, it is advisable to exercise caution and consider avoiding this strategy during bear markets. To qualify for the dividend, it is necessary to buy the stock before the ex-dividend date and refrain from selling it until on or after the ex-date.
However, it is important to note that the actual dividend may not be paid for several weeks, as the payment date may not be until two months after the ex-dividend date.
For investors seeking a comprehensive list of stocks going ex-dividend in the near future, WallStreetNewsNetwork.com has compiled a downloadable list containing numerous dividend-paying companies. Here are a few examples showcasing the stock symbol, ex-dividend date, periodic dividend amount, and annual yield.
Costco Wholesale Corporation (COST)
8/1/2025
1.30
0.56%
American Electric Power Company, Inc. (AEP)
8/8/2025
0.93
3.41%
Starbucks Corporation (SBUX)
8/15/2025
0.61
2.60%
Horizon Technology Finance Corporation (HRZN)
8/18/2025
0.11
15.68%
Applied Materials, Inc. (AMAT)
8/21/2025
0.46
0.98%
Microsoft Corporation (MSFT)
8/21/2025
0.83
0.65%
CSX Corporation (CSX)
8/29/2025
0.13
1.49%
T-Mobile US, Inc. (TMUS)
8/29/2025
0.88
1.42%
To access the entire list of over 100 ex-dividend stocks, subscribers will receive an email in the next couple days with the full list. If you are not already a subscriber, you can sign up using the provided signup box below. Don’t miss out on this valuable information, and the best part is that it’s free!
Dividend Definitions
To better understand the dividend-related terms, let’s define them:
Declaration date: This refers to the day when a company announces its intention to distribute a dividend in the future. Ex-dividend date: On this day, if you purchase the stock, you would not be eligible to receive the upcoming dividend. It is also the first day on which a shareholder can sell their shares and still receive the dividend. Record date: This marks the day when you must be recorded on the company’s books as a shareholder to qualify for the dividend. Typically, the ex-dividend date is set two business days prior to the record date. Payment date: This is the day on which the dividend payment is actually made to the eligible shareholders. It’s important to note that the payment date can be as long as two months after the ex-date.
Before implementing the “Buying Dividends” technique, it is crucial to reconfirm the ex-dividend date with the respective company to ensure accuracy and avoid any unexpected changes.
In conclusion, being aware of the stocks going ex-dividend can be advantageous for traders and investors employing the “Buying Dividends” strategy. WallStreetNewsNetwork.com provides a convenient resource to access a comprehensive list of such stocks, allowing individuals to plan their investment decisions effectively. Remember to stay informed and consider market conditions before employing any investment strategy.
Disclosure: Author may have positions in some of the above at the time the article was written.
The Indiana Jones Whip recently sold for $525,000 at the summer Heritage Auction, and the Rosebud sled that appeared in Citizen Kane was hammered at an incredible $14.75 million. Last December, Judy Garland’s Ruby Slippers from The Wizard of Oz went for $28 million at another auction, with an expectation of selling for only $3 million.
In recent years, collecting rare movie props has emerged as a niche yet lucrative investment category for those seeking alternatives to traditional assets. Movie props carry a unique combination of historical significance, nostalgia, and cultural relevance that can transcend market volatility. A prop is not merely a physical object; it is a tangible piece of cinematic history. For investors and collectors alike, owning a screen-used lightsaber from Star Wars or Indiana Jones’s whip from Raiders of the Lost Ark represents a direct connection to a film that has defined generations. This emotional connection underpins the steady demand for authentic memorabilia, which in turn drives value appreciation over time.
The key to successful investing in movie props lies in authenticity, provenance, and cultural impact. Items that are screen-used, especially if featured prominently or used by a leading actor, command the highest premiums. For example, in 2023, an original X-wing model used in Star Wars: A New Hope sold for over $3 million at auction, far exceeding its presale estimates. Similarly, Marilyn Monroe’s “subway dress” from The Seven Year Itch fetched $4.6 million in 2011. These landmark sales illustrate how props tied to iconic scenes or legendary actors can yield returns surpassing conventional collectibles like coins or stamps.
However, investing in movie props requires diligence. The market is unregulated, so verifying authenticity is paramount. Certificates of authenticity (COAs), studio paperwork, and detailed provenance records help establish credibility and future resale value. Investors should also consider storage and conservation, as many props are fragile and susceptible to deterioration if not preserved under proper temperature and humidity conditions. Engaging with reputable auction houses, specialized dealers, and industry experts minimizes risks and ensures informed acquisitions.
Beyond financial considerations, collecting movie props offers intangible rewards. It provides access to exclusive communities of collectors, film historians, and studio insiders, deepening one’s appreciation of cinema as an art form. For investors passionate about film, owning a rare prop is a daily inspiration that no traditional stock certificate can replicate. Ultimately, while movie props remain an unconventional investment, their rarity, emotional resonance, and record-breaking auction performances have proven them to be a compelling addition to diversified alternative asset portfolios.
The following is a short list of some of the many stocks going ex-dividend during the next month, which can be helpful for traders and investors interested in the stock trading technique known as “Buying Dividends” or “Dividend Capture.” This strategy involves purchasing stocks before the ex dividend date and selling them shortly after the ex-date at a similar price, while still being eligible to receive the dividend payment.
Although this dividend capture strategy generally proves effective in bull markets and flat or choppy markets, it is advisable to exercise caution and consider avoiding this strategy during bear markets. To qualify for the dividend, it is necessary to buy the stock before the ex-dividend date and refrain from selling it until on or after the ex-date.
However, it is important to note that the actual dividend may not be paid for several weeks, as the payment date may not be until two months after the ex-dividend date.
For investors seeking a comprehensive list of stocks going ex-dividend in the near future, WallStreetNewsNetwork.com has compiled a downloadable list containing numerous dividend-paying companies. Here are a few examples showcasing the stock symbol, ex-dividend date, periodic dividend amount, and annual yield.
Cisco Systems, Inc. (CSCO)
7/3/2025
0.41
2.39%
Verizon Communications Inc. (VZ)
7/10/2025
0.68
6.22%
Abbott Laboratories (ABT)
7/15/2025
0.59
1.76%
Lowe’s Companies, Inc. (LOW)
7/23/2025
1.2
2.10%
Delta Air Lines, Inc. (DAL)
7/31/2024
0.1875
1.07%
To access the entire list of over 100 ex-dividend stocks, subscribers will receive an email in the next couple days with the full list. If you are not already a subscriber, you can sign up using the provided signup box below. Don’t miss out on this valuable information, and the best part is that it’s free!
Dividend Definitions
To better understand the dividend-related terms, let’s define them:
Declaration date: This refers to the day when a company announces its intention to distribute a dividend in the future. Ex-dividend date: On this day, if you purchase the stock, you would not be eligible to receive the upcoming dividend. It is also the first day on which a shareholder can sell their shares and still receive the dividend. Record date: This marks the day when you must be recorded on the company’s books as a shareholder to qualify for the dividend. Typically, the ex-dividend date is set two business days prior to the record date. Payment date: This is the day on which the dividend payment is actually made to the eligible shareholders. It’s important to note that the payment date can be as long as two months after the ex-date.
Before implementing the “Buying Dividends” technique, it is crucial to reconfirm the ex-dividend date with the respective company to ensure accuracy and avoid any unexpected changes.
In conclusion, being aware of the stocks going ex-dividend can be advantageous for traders and investors employing the “Buying Dividends” strategy. WallStreetNewsNetwork.com provides a convenient resource to access a comprehensive list of such stocks, allowing individuals to plan their investment decisions effectively. Remember to stay informed and consider market conditions before employing any investment strategy.
Disclosure: Author may have positions in some of the above at the time the article was written.
